Graham Capital Management L.P. acquired a new stake in shares of Humana Inc. (NYSE:HUM – Get Rating) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,067 shares of the insurance provider’s stock, valued at approximately $1,334,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Riverview Trust Co purchased a new position in Humana during the first quarter valued at approximately $32,000. Transcend Capital Advisors LLC grew its position in Humana by 18.3% in the first quarter. Transcend Capital Advisors LLC now owns 587 shares of the insurance provider’s stock worth $255,000 after acquiring an additional 91 shares in the last quarter. Krane Funds Advisors LLC grew its position in Humana by 4.2% in the first quarter. Krane Funds Advisors LLC now owns 889 shares of the insurance provider’s stock worth $387,000 after acquiring an additional 36 shares in the last quarter. CCLA Investment Management Ltd grew its position in Humana by 1.4% in the first quarter. CCLA Investment Management Ltd now owns 218,232 shares of the insurance provider’s stock worth $95,075,000 after acquiring an additional 3,034 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in Humana in the first quarter worth approximately $800,000. 93.50% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts have commented on the stock. Cowen boosted their target price on shares of Humana to $547.00 in a research report on Tuesday, August 9th. Credit Suisse Group set a $548.00 target price on shares of Humana in a research report on Tuesday, July 19th. Truist Financial boosted their price objective on shares of Humana from $490.00 to $550.00 and gave the stock a “hold” rating in a research note on Thursday, July 14th. Morgan Stanley boosted their price objective on shares of Humana from $453.00 to $494.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Humana from $450.00 to $514.00 in a research note on Thursday, July 28th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $512.39.
Humana Price Performance
Humana (NYSE:HUM – Get Rating) last released its earnings results on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, beating the consensus estimate of $7.67 by $1.00. Humana had a net margin of 3.52% and a return on equity of 18.42%. The firm had revenue of $23.66 billion during the quarter, compared to analysts’ expectations of $23.44 billion. During the same period in the prior year, the company earned $6.89 EPS. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. Analysts anticipate that Humana Inc. will post 24.85 earnings per share for the current year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be paid a $0.7875 dividend. This represents a $3.15 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, September 29th. Humana’s dividend payout ratio is 12.86%.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Get a free copy of the StockNews.com research report on Humana (HUM)
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- Here’s Why the CPI Report will Dictate the Market Bottom
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.